spacer
home >
PUBLICATIONS

 
 
 

spacer

 

Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

 
News and Press Releases

Infection control has never been more important, letís use innovation to solve this ongoing issue in our healthcare

In our lifetime, there has rarely been a greater sense of camaraderie than over the past year. The nation united under a common health threat and the common good delivered by a National Health Service at their time of need. In March 2020 the world was forced to stop, readjust, and overcome the barriers this virus has inflicted upon us all. Whilst it has sadly been a tragedy for so many businesses, households, and livelihoods, it has by no means stopped great British ideas, ingenuity, and innovation. The 5.9 million UK SMEs, which make up 99% of all business, generating 54% of all UK employment, have demonstrated remarkable resilience in the face of such adversity, and are at the forefront of the Governmentís Levelling-Up agenda in the post-Covid-19 world that we are all starting to see at the end of the tunnel.
More info >>

 
White Papers

Case Study: Getting the Clientís Trust - Oncology Program

Cmed Clinical Services

Five years ago, a biopharmaceutical company chose Cmed to conduct a phase II oncology study. Cmedís performance of the study and the good relationship established with the Client led Cmed to be awarded a second oncology trial which a couple of years ago was followed by a third, fourth and fifth.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement